AZ sues McKesson over inflated drug prices
The state of Arizona has filed a lawsuit against McKesson Corp., alleging the nation's largest drug wholesaler has artificially inflated the prices of more than 400 brand-name prescription drugs. Among the drugs that are alleged to have been marked-up inappropriately are: Allegra, Azmacort, Celebrex, Coumadin, Flonase, Lipitor, Neurontin, Nexium, Prevacid and Valium. The complaint was filed in Maricopa County Superior Court, alleging that the scheme began in 2000 to mark up the average wholesale price of many prescription drugs, costing consumers millions of dollars, according to Arizona Attorney General Tom Horne. The San Francisco company controls about one-third of the national wholesale drug distribution market, Horne said.
- CMS Sets 2014 Pay Rates for Hospital Outpatient and Physician Services
- FDA hopes hospitals will switch to newly regulated pharmacies
- The 5 Biggest Healthcare Finance Trouble Spots
- Not-for-Profit Hospitals Find Opportunity Amid Uncertainty
- Nonprofit Hospital Outlook 'Negative' in 2014
- The Most Polarizing Topics in Healthcare IT
- How CPOE Will Make Healthcare Smarter
- Are ACOs Really Different from HMOs?
- Why You Should Involve Patients in Nursing Handoffs
- Rise of the Chief Strategy Officer